Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Safonov

Showing results (251-260 of 816) with videos related to

Pageof 82
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Tetrasubstituted pyridines as potent and selective AKT inhibitors: Reduced CYP450 and hERG inhibition of aminopyridinesHong Lin, Dennis S Yamashita, Ren Xie, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
APOBEC3 mutagenesis drives therapy resistance in breast cancerAvantika Gupta, Andrea Gazzo, Pier Selenica, et al.
Nature Genetics|May 16, 2025
APOBEC3 mutagenesis drives therapy resistance in breast cancerAvantika Gupta, Andrea Gazzo, Pier Selenica, et al.
Biomedicines|October 26, 2024
The Wound-Healing Effect of a Novel Fibroblasts-Impregnated Hydroxyethylcellulose Gel in a Rat Full-Thickness Burn Model: A Preclinical StudyYury A Novosad, Anton S Shabunin, Natella I Enukashvily, et al.
Cancer Cell|October 11, 2024
Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversionRei Kudo, Anton Safonov, Catherine Jones, et al.
Nature Communications|April 1, 2025
A genotype-first approach identifies high incidence of NF1 pathogenic variants with distinct disease associationsAnton Safonov, Tomoki T Nomakuchi, Elizabeth Chao, et al.
Cancer Discovery|September 1, 2022
Genetic Ancestry Correlates with Somatic Differences in a Real-World Clinical Cancer Sequencing CohortKanika Arora, Thinh N Tran, Yelena Kemel, et al.
Cell|December 19, 2024
Pan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancerMark Zucker, Maria A Perry, Samuel I Gould, et al.
Kardiologiia|December 9, 2021
[Focus ultrasound for cardiology practice. Russian consensus document]Yu V Mareev, O N Dzhioeva, O T Zorya, et al.
Journal of Medicinal Chemistry|September 20, 2008
Identification of 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a novel inhibitor of AKT kinaseDirk A Heerding, Nelson Rhodes, Jack D Leber, et al.
Pageof 82

Showing results (251-260 of 816) with videos related to

Sort By:
Pageof 82
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Tetrasubstituted pyridines as potent and selective AKT inhibitors: Reduced CYP450 and hERG inhibition of aminopyridinesHong Lin, Dennis S Yamashita, Ren Xie, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
APOBEC3 mutagenesis drives therapy resistance in breast cancerAvantika Gupta, Andrea Gazzo, Pier Selenica, et al.
Nature Genetics|May 16, 2025
APOBEC3 mutagenesis drives therapy resistance in breast cancerAvantika Gupta, Andrea Gazzo, Pier Selenica, et al.
Biomedicines|October 26, 2024
The Wound-Healing Effect of a Novel Fibroblasts-Impregnated Hydroxyethylcellulose Gel in a Rat Full-Thickness Burn Model: A Preclinical StudyYury A Novosad, Anton S Shabunin, Natella I Enukashvily, et al.
Cancer Cell|October 11, 2024
Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversionRei Kudo, Anton Safonov, Catherine Jones, et al.
Nature Communications|April 1, 2025
A genotype-first approach identifies high incidence of NF1 pathogenic variants with distinct disease associationsAnton Safonov, Tomoki T Nomakuchi, Elizabeth Chao, et al.
Cancer Discovery|September 1, 2022
Genetic Ancestry Correlates with Somatic Differences in a Real-World Clinical Cancer Sequencing CohortKanika Arora, Thinh N Tran, Yelena Kemel, et al.
Cell|December 19, 2024
Pan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancerMark Zucker, Maria A Perry, Samuel I Gould, et al.
Kardiologiia|December 9, 2021
[Focus ultrasound for cardiology practice. Russian consensus document]Yu V Mareev, O N Dzhioeva, O T Zorya, et al.
Journal of Medicinal Chemistry|September 20, 2008
Identification of 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a novel inhibitor of AKT kinaseDirk A Heerding, Nelson Rhodes, Jack D Leber, et al.
Pageof 82